The Safer Prescription of Opioids Tool USA Market feasibility study

Spot--更安全的阿片类药物处方工具是一个新型的数字健康平台，以软件即服务的形式分发，事实证明，这大大提高了阿片类药物处方的信心和对最佳做法指南的遵守。Spot已被BBC特写，并被SDI评为2020年最值得关注的12大数字健康创新之一。Spot已被纳入苏格兰政府的19型冠状病毒姑息治疗反应工具包。继最近的IUK项目之后，Spot与总部位于英国和欧洲的专业出版分销商Class Professional出版公司建立了合作伙伴关系。截至2021年4月，SPOT现已在其Salesforce平台上面向全欧洲提供，并辅之以一线销售和技术支持。基于过去两年产生的具体联系、我们在英国和欧洲市场的进展以及新冠肺炎疫情带来的数字健康势头的增强，我们寻求与已经表示对Spot感兴趣的美国潜在商业合作伙伴进行可行性研究。

SPOT - The Safer Prescription of Opioids Tool is a novel digital health platform, distributed as software as a service, which is proven to significantly improve the confidence of opioid prescribing and adherence to best practice guidelines. SPOT has been featured by the BBC and is one of SDI's top 12 Digital Health innovations to watch in 2020\. SPOT has been included in the Scottish Government's Coronavirus 19 palliative care response toolkit.Following a recent IUK project, SPOT has partnered with a UK and European-based professional publishing distributor, Class Professional Publishing. As of April 2021, SPOT is now available Europe-wide on their Salesforce platform, complemented with first-line sales and technical support.Building on specific contacts engendered over the last two years, our progress in the UK and European markets, and an increase in momentum for digital health from the COVID-19 pandemic, we seek to carry out a feasibility study with potential commercial partners in the USA who have already expressed interest in SPOT.